PCYC
{"sector":"Healthcare","industry":"Drugs","symbol":"PCYC","company_name":"PHARMACYCLICS, INC.","exchange":"NASDAQ"}PCYC Articles
Independent research firm Argus has maintained its Buy rating and its $85.00 price target on AbbVie.
Published:
There were some interesting positions of hedge funds in biotech, long and short, from the Goldman Sachs Hedge Fund Trend Monitor.
Published:
24/7 Wall St. has found four good examples of blue-chip stocks that got a little tarnished recently for one reason or another, that investors may want to reexamine.
Published:
Here are three biotech stocks that a SunTrust analyst feels could be buyout candidates, in the wake of the Pharmacyclics acquisition.
Published:
News finally broke late Wednesday that there was an official buyout of Pharmacyclics in the works by AbbVie for $21 billion.
Published:
Friday's top analyst upgrades, downgrades and initiations include Bank of America, CA, CBOE, CSX, FedEx, ITT and Potbelly.
Published:
Thursday's top analyst upgrades, downgrades and initiations from 24/7 Wall St. include Coach, Garmin, Intelsat, Potbelly, SolarCity and Valero Energy.
Published:
ThinkstockLooking back at 2014, biotechs had a phenomenal year, and this looks to continue into 2015. The NYSE Arca Biotech index was up over 45% for 2014, and Wells Fargo expects that the biotech...
Published:
Last Updated:
A new research report from Baird highlights the firm's top picks for 2015. We screened the Baird list, which is a very diverse and solid group of picks, for the momentum stocks they tout as top picks...
Published:
Last Updated:
With the bull market nearing six years old, 24/7 Wall St. has identified 11 large and well-known stocks that are valued at over 50 times earnings.
Published:
SunTrust Robinson Humphrey opens up coverage of the biotech sector with four top biotech stocks to buy and one Neutral-rated stock.
Published:
In a research note, Leerink analysts mentioned four specific top biotech names that may have the ability to beat current earnings expectations. But 24/7 Wall St. has one caveat.
Published:
A new research note from Credit Suisse maintains that the top large cap biotech leaders are leading the comeback rally from the hard sell-off. Here are the top large cap biotech stocks to buy at...
Published:
Last Updated:
ThinkstockAs the summer starts, a large agenda is out there for investors when it comes to top biotech and specialty pharmaceutical companies making announcements and presenting clinical data. The...
Published:
Thinkstock24/7 Wall St. has tracked the short interest in leading biotech and emerging pharmaceutical stocks. Many biotech stocks pulled back in late March, and short sellers moved in on many of...
Published: